Loading clinical trials...
Loading clinical trials...
SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression: A Study to Evaluate Safety and Effectiveness of Self-Forming Magnet (SFM) Anastomosis Device: A Historically Controlled Propensity Matched Study
The objectives of this study are to determine the safety and effectiveness of the SFM Anastomosis Device when used to create a small bowel anastomosis for patients undergoing ileostomy reversal as compared with a propensity-matched historic control group of patients who underwent ileostomy reversal using a conventional closure technique (sutures or stapler).
This is a multicenter, single-arm study in which clinical outcomes prospectively evaluated for a minimum of 100 subjects undergoing ileostomy reversal using the SFM Anastomosis Device will be 1:1 propensity score matched through nearest neighbor matching to a historical control cohort of patients who underwent ileostomy reversal using conventional closure techniques. In order to have a sufficient pool of retrospective patients for matching, retrospective data will be collected for a minimum of 300 patients. The historical control cohort will be accrued from the same pool of institutions participating in the prospective study. Eligibility criteria will be standardized between the prospective investigational treatment arm and the historical control. Within this analysis, propensity score (PS) matching will be used to reduce bias due to potential differences in key covariates between the prospective and retrospective cohorts.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Advent Health
Orlando, Florida, United States
Colon and Rectal Clinical of Orlando
Orlando, Florida, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Spectrum Health / Ferguson Clinic
Grand Rapids, Michigan, United States
Trinity Health Michigan Heart
Ypsilanti, Michigan, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
The Mount Sinai Medical Center
New York, New York, United States
St Francis Hospital
Roslyn, New York, United States
Novant Health Clinical Research
Winston-Salem, North Carolina, United States
Start Date
February 1, 2022
Primary Completion Date
October 1, 2023
Completion Date
December 30, 2023
Last Updated
October 15, 2024
128
ACTUAL participants
Ileostomy Reversal using Self Forming Magnets (SFM)
DEVICE
Lead Sponsor
GI Windows, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions